Arkolith/Insider Trading/CDTX/Form 4

Kolchinsky Peter

Director, 10% OwnerCidara Therapeutics, Inc. (CDTX) · full profile →Form 4 · filed Jun 30, 2025
Net Buying
Open-Market Buys
$100.0M
Open-Market Sells
$0
Net Open-Market Flow
$100.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 26, 2025Buy(P)2.3M$44.00$100.0M3.4M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-018516) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML